
|Articles|June 1, 2003
Doxorubicin, Interleukin-12 Join Against KS
Boston - Combined cytotoxic and antiangiogenic therapies may have synergistic effects in treating advanced Kaposi's sarcoma in patients with AIDS, according to Richard F. Little, M.P.H., M.D., senior clinical investigator, HIV and AIDS malignancy branch, Center for Cancer Research, National Cancer Institute.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
FDA Updates iPLEDGE REMS with New Modifications for Pregnancy Testing and Prescription Windows
2
New Phase 3 DISCREET Data Supports Long-Term Use of Apremilast for Genital Psoriasis
3
Targeting MRGPRX2: Early Human Data for a Novel CSU Approach
4
Phase 3 Results Signal a New Era for Oral Targeted Therapy in Psoriasis
5










